This week, the U.S. Supreme Court will take up one of the most important civil rights cases of the last decade when it considers the case of Texas Department of Housing and Community Affairs v. The Inclusive Communities Project. The case concerns whether the Fair Housing Act, which sought to end the longstanding segregation of America’s neighborhoods, should be read to only bar intentional discrimination. For four decades, federal courts have held that the law should be interpreted more broadly.Full Story»
An investigation by ProPublica examines information from a database known as Open Payments, which gives the first comprehensive look at how much money drug and device companies have spent working with doctors. What it shows is that the drugs most aggressively promoted to doctors typically aren’t cures or even big medical breakthroughs. Some are top sellers, but most are not.
As the Federal Reserve Bank of New York moved to beef up its oversight of Wall Street two years ago, the team charged with supervising the nation’s largest bank, JPMorgan Chase, was in turmoil. Fed examiners embedded at JPMorgan complained about being blocked from doing their jobs. In frustration, some requested transfers.
California Gov. Jerry Brown signed into law a bill holding the state’s employers legally responsible for wage and safety violations committed by their subcontractors and temp agencies. With the new law, California will have some of the country’s farthest-reaching protections for temporary workers, among the fastest growing and most vulnerable segments of the workforce.
More in this category
- Inside the New York Fed: Secret Recordings and a Culture Clash
- Geithner Book: ‘I Should Have Paid More Attention’ to Citigroup’s Woes
- Power Tool Makers Accused of Thwarting Adoption of Finger-Saving Device
- Stunning Loss for Lead Paint Makers in California Lawsuit
- GlaxoSmithKline to Quit Paying Doctors for Promotional Talks
- Court Asked to Decide if Transparency Trumps Corporate Reputation in ‘Company Doe’ Case